Japanese cedar pollinosis
Conditions
Interventions
Group A:intranasal corticosteroid(100microgram,once a day) and intranasal anti-histamine(0.05mg, four times a day)(2 weeks:from March 1 to March 15)
Group B:intranasal corticosteroid(100microgram, onc
Sponsors
Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Department of Otolaryngology-Head & Neck Surgery
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: The patients of Japanese cedar pollinosis(between the age of 16 and 65 years, for at least a 2-year history of Japanese cedar pollinosis)
Exclusion criteria
Exclusion criteria: 1)concomitant sinonasal disease that could potentially affect the outcome of the trial (e.g., rhinosinusitis with nasal polyps, nasal septum deviation) 2)concomitant treatment for AR caused by allergens other than Japanese cedar pollen 3)rhinitis medicamentosa and non-allergic rhinitis 4)medication with anti-allergic drugs including H1RA, chromones, glucocorticoids and decongestants within 2 weeks of study initiation 5)sinonasal surgery including laser vaporization of inferior turbinates within 1 year 6)hypersensitivity to intranasal corticosteroid or intranasal ant-histamine 7)systemic infection including mycosis 8)pregnancy and breastfeeding
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total nasal symptom score | — |
Secondary
| Measure | Time frame |
|---|---|
| Total ocular symptom score, total symptom score, and QOL score | — |
Countries
Japan
Contacts
Public ContactTakenori Haruna
Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Department of Otolaryngology-Head & Neck Surgery
Outcome results
None listed